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Introduction 
The purpose of this paper is to discuss recent legislative changes about requiring 
mandatory vaccination of adolescents with Gardasil.  In October 2006, Gardasil was approved by 
the Food and Drug Administration (FDA) to help prevent cervical, vaginal, and vulvar cancer 
caused by the Human Papilloma Virus (HPV).  HPV is the virus responsible for genital warts 
through which are transmitted through sexual contact.  The vaccine was originally intended for 
use in females, but is now recommended for use in males as well.  Regardless of the gender of 
the individual, there is controversy about the need for the vaccine.  The Gardasil vaccine is 
intended to be administered before an individual is exposed to HPV, hence young adolescents 
ages 11 and 12 are the targeted age group since the majority of them have yet to engage in sexual 
activity.  Many parents, however, feel that once their child receives this vaccine that the child 
will then feel free to participate in sexual activities since they are “protected” from HPV.  Also, 
there is a new issue surrounding the Gardasil vaccine’s recent addition to the Center for Disease 
Control’s (CDC) Childhood Immunization Schedule.  Subsequently several states are pursuing 
legislation to require the vaccination prior to school attendance.  This paper will look at the 
ethical issue of a state mandate requiring an adolescent to be vaccinated with Gardasil.  
I choose to write about this topic because I have received the vaccine.  When I was a 
senior in high school, the vaccine had just been approved and my parents were excited to help 
protect me in any way they could.  However one day my mother mentioned to a coworker that 
her daughter was going to get “that new HPV vaccine.”  The coworker not so enthusiastically 
replied, “Oh, my daughter won’t be needing that.”  Regardless, I did receive the vaccine, yet 
controversy still exists today as to whether this vaccine is a go-ahead for adolescents to engage in 
sexual behaviors.  Additionally, I am partial to this topic as I am a peer educator through the 
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Coterie Theater, teaching HIV/AIDS and sexual transmitted disease (STD) prevention to local 
teens in the Kansas City area.  Often times I am asked by students about the vaccine, whether 
they should get it, and whether it is a cure.  These types of questions clearly show the lack of 
education regarding this important new vaccine.  It is imperative that the issues surrounding the 
Gardasil vaccine be addressed and brought to the attention of public so that adolescents can 
make clear, informed decisions when trying to protect themselves.        
About HPV and the Vaccine 
According to the Centers for Disease Control and Prevention (CDC), “HPV infects 
approximately 20 million people in the United States with 6.2 million new cases each year,” and 
“cervical cancer is the second leading cancer killer of women worldwide.”  In the United States, 
nearly “10,000 women are diagnosed with cervical cancer each year and 3,700 of these women 
die each year from this disease” (CDC, 2010, pg. 620).  A Papanicolaou test (Pap smear) can be 
used to diagnose an HPV infection.   It is recommended that sexually active women have an 
annual Pap smear exam to look for this virus and discuss other well woman issues.  It is 
important to note that there is no cure for HPV, only treatment for related health problems.   
As mentioned above, the Gardasil vaccine was approved by the FDA in October, 2006 to 
help “prevent four specific strains of HPV (6, 11, 16, and 18)” (McLemore, 2006, pg. 559).  
More importantly, “nearly 70 percent of cervical cancer cases and 90 percent of genital warts 
cases are linked to these four strains of HPV” (Hanson, 2010, pg. 1).  Gardasil was created by the 
Merck Sharp & Dome pharmaceutical company as a prophylactic measure for the prevention of 
cervical cancer; it is not a cure for cervical cancer.  The vaccine is a series of three intramuscular 
shots administered over six months and is targeted at “females age 11 and 12, but can be 
administered up to the age of 26” (Contraceptive Technology Update, 2007, pg. 32).  It is a 
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recombinant vaccine that produces an immune response within the recipient while causing no 
risk of contracting the original disease, HPV.  This immune response allows the recipient to 
produce antibodies against the four specific strains of HPV so that he or she will be able to 
defend against the virus if ever exposed.  Additionally, as of October, 2009, the Gardasil vaccine 
was licensed “for use in males aged 9 through 26 years for prevention of genital warts” (CDC, 
2010, pg. 620). 
Issues 
Gardasil has been proven to be “more effective when administered prior to exposure to 
HPV,” which is before the initiation of sexual activity (Contraceptive Technology Update, 2008, 
pg. 127).  Moreover, “in the U.S., sexual activity begins in ninth grade for 29.3% of girls, and 
62.4% of twelfth grade girls report prior sexual activity” (Caron, Kispert, & McGrath, 2009, pg. 
2).  Consequently the targeted ages for both female and male recipients are ages 11 and 12.  
Currently, the CDC has updated the National Childhood Immunization schedule for children and 
adolescents to include “Gardasil, the first (HPV) vaccine…for females ages 11 to 12, and 
permissive use of the vaccine in females as early as age 9 and up to age 26,” (Contraceptive 
Technology Update, 2007, pg. 32).  Given that this is the targeted age group, several states have 
begun requiring that young girls entering sixth grade in the public schools receive the Gardasil 
vaccination prior to attendance.  Having a state mandate that all school girls be vaccinated 
against HPV has become an extremely controversial issue. 
It is not unheard of for a state to require a child to receive a specific vaccination to attend 
school.  Nearly every state mandates that school children receive most of the other vaccines in 
the Childhood Immunization schedule, such as those for tetanus, hepatitis B, chickenpox, and 
measles.  The CDC creates these recommended immunization schedules so that the public may 
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be protect from serious, potential harm.   However, it is important to take into account that never 
before has a vaccine been required for simply one gender of school children.  School vaccination 
requirements are decided by state legislatures and regulatory bodies.  On February 2, 2007, 
“Texas became the first state to enact a mandate by executive order from the governor that all 
females entering the sixth grade receive the vaccine;” however, “legislators in Texas passed H.B. 
1098 to override the executive order” (Hanson, 2010, pg. 2).  Following Texas’ actions, “19 
states introduced and enacted legislation to require, fund or educate the public about the HPV 
Vaccine, including Colorado, Indiana, Iowa, Louisiana, Maine, Maryland, Michigan, Minnesota, 
Nevada, New Mexico, New York, North Carolina, North Dakota, Rhode Island, South Dakota, 
Texas, Utah, Virginia and Washington,” (Hanson, 2010, p. 2).      
Reasons for controversy are vast, yet they center on the fact that some parents have 
problems giving a vaccine against an STD to adolescents. Other parents might “not want a 
vaccine against an STD at all, believing that their children could not be at risk, even though most 
reports show that half of high school students are having sex” (Iannelli, 2010, pg. 1).   Still others 
think that Gardasil might encourage promiscuity among adolescents, since it could foster the 
belief that the vaccine “protects” against STDs.  The reality is that Gardasil does not protect 
against other STDs, just HPV.  Since HPV is spread through sexual contact, many parents are 
hesitant to talk to their adolescents about the issues surrounding this vaccine.   
Review of Literature: Supporting 
Although the vaccine is fairly expensive, the Contraceptive Technology Update looked at 
the cost effectiveness of receiving the vaccine.  The study took into account the cost of the 
vaccine, yearly Pap smear screenings, and the cost of treating cervical cancer and other illnesses 
targeted by the vaccine.  Analysis findings  indicated that “vaccination against HPV-16 and 
The Journal of Undergraduate Nursing Writing. Volume 5, Issue 1. August 2011. 7
HPV-18 would lead to lower cervical cancer rates and be economically attractive if high 
coverage can be achieved in the most important target group of 12-year-old girls” (Contraceptive 
Technology Update, 2008, p. 127).  Meaning that, while the Gardasil vaccine may appear 
expensive to frugal consumers, it would prove beneficial to pay for one vaccine rather than 
spending large sums of money later in life for continuous, expensive treatments of cervical 
cancer.  Additionally, because the Gardasil vaccine is included in the CDC’s Childhood 
Immunization schedule, it is available to young women 18 and younger who “are Medicaid-
eligible, uninsured, American Indian or Alaska Native, or underinsured and many insurance 
companies are setting policy for reimbursement for the vaccine,” (Contraceptive Technology 
Update, 2007, pg. 32). 
Concerning the administration of Gardasil, findings from a recent study of Australian 
teens ages 12-18 indicate that “hypersensitivity reactions to the vaccine are uncommon and most 
girls in this age range can tolerate subsequent doses,” yet observation for 15 minutes after 
administration is recommended (Contraceptive Technology Update, 2009, pg. 14).   As with 
many other vaccines, fainting and dizziness are common side effects after receiving Gardasil and 
some injection site tenderness was also noted, especially after the third and final dose.  Since 
administration of the vaccine is well tolerated, it can foster positive interactions between 
providers and their young female clients.  Not only does Gardasil help protect young women 
from contracting HPV, but it also “offers family planning programs an important way to serve 
young girls and initiate at a very young age the discussion of the use of contraception to prevent 
unintended pregnancy” (Contraceptive Technology Update, 2008, pg. 127).  This important 
conversation leads to further discussions between young women and their care providers about 
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the necessity of protection to prevent pregnancy and other STDs, as well as how to avoid being a 
victim of physical or sexual abuse.   
Today, the Gardasil vaccine is approved for use in males as well as females.  In males 
HPV generally causes genital warts, but can also be linked to certain anal, penile, and 
oropharyngeal cancers.  Warts specifically have an adverse effect on quality of life and cost an 
estimated “$200 million per year in direct medical costs” (CDC, 2010, pg. 630).  The vaccination 
of young men is especially important considering “HPV infection in men has been shown to 
contribute to HPV infection and subsequent cervical disease in women,” and there is a high rate 
of transmission of HPV in female partners of men with pre-existing penile warts (Contraceptive 
Technology Update, 2009, pg. 14).  More importantly, “if large numbers of girls and women do 
not obtain the recommended vaccinations, then vaccination of men and boys could play a 
significant role in lowering infection rates among males and females,” (Contraceptive 
Technology Update, 2009, pg. 14).  Through vaccinating young men, practitioners are not only 
decreasing the incidence of genital warts in this population, but they are also decreasing the 
chance that these individuals pass HPV to their partners later in life.  By applying the concept of 
herd immunity, where 80% of a population is vaccinated against a certain disease and thus the 
entire population is then considered immune, health care providers can reduce the overall 
occurrence of HPV infections in both males and females.   
In general, the Gardasil vaccine is largely approved.  A recent study noted that not only 
did "70.2% accept vaccination for girls,” but that after introduction to the Gardasil vaccine, 
“HPV awareness increased"(Christian, Christian, & Hopenhayn, 2009, pg. 439).  Even 
organizations such as Focus on the Family and the Christian Medical Association that don't 
believe the vaccine should be mandatory, strongly support the vaccine itself.  This may be due to 
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the fact that whether or not an adolescent receives the vaccine, awareness about HPV and 
associated risky behaviors has increased overall.  Adolescents are now more aware that the 
actions they choose to take today may affect them for the rest of their lives.  Furthermore, the 
most apparent and probably most obvious reason for the acceptance of the vaccine is that 
“Gardasil is the first vaccine that may actually prevent a cancer” (Nelson, 2007, pg. 23).  With 
the exception of the Hep B vaccine that is targeted to prevent liver cancer, there are very few 
vaccines that can make this astounding claim.  There is no cure for cancer, so any vaccine that 
can help prevent such a devastating disease is truly amazing. 
Review of Literature: Opposing 
A significant disadvantage of the Gardasil vaccine is related to the cost.  According to the 
Contraceptive Technology Update in 2008, the vaccine series “costs about $360,” not including 
the associated costs of office visits.  While the vaccine is beginning to be accepted and covered 
by many health insurance companies, it is still an added expense.  Considering that HPV is 100% 
preventable through abstinence from sexual activity, many parents may not see the importance of 
having their child receive a vaccine such as this.  Therefore, the cost alone may deter some 
parents from having their children vaccinated with Gardasil. 
Many experts are concerned that with the protection Gardasil provides, the female 
population may "become apathetic about continuing regular cervical screenings,” and stop 
scheduling yearly Pap smears all together (Calder, 2009, pg. 20).  In order for the vaccine to be 
effective a strong national cervical screening program must be maintained and promoted by all 
practitioners.  To elaborate this point, “if the community is led to believe they are protected 
against cervical cancer and do not maintain regular cervical screenings, there may actually be an 
increase in the incidence of cervical cancer” (Calder, 2009, pg. 20).  This issue must be in the 
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forefront of any medical practitioner’s mind when discussing or administering the Gardasil 
vaccine to female clients.  The individual must impart the purpose of the vaccine; that it protects 
against only four strains of HPV; and stress the importance of continuing yearly Pap smear 
exams.  Practitioners must discuss the fact that engaging in unprotected sex with multiple sex 
partners are risk factors for contracting HPV and even individuals that have been vaccinated 
should refrain from these activities.  Additionally when discussing the annual Pap smear, the 
practitioner must remind female clients that the Pap smear looks for more than just cervical 
cancer and can help detect other STDs and abnormalities that may also require medical attention.   
Finally, questions remain about Gardasil’s overall effectiveness, the duration of its 
protection, and possible long-term adverse effects.  A “total of 10,326 adverse events following 
immunization [with Gardasil] were reported,” with syncope and fall related injuries being the 
worst (Contraceptive Technology Update, 2009, pg.14).   While monitoring for 15 minutes after 
vaccine administration is recommended, this may not always be performed or documented.  Data 
obtained from clinical trials ahs shows that Gardasil is “100 percent effective against [HPV] 
types 16 and 18,” yet it is unknown how effective the vaccine is against HPV strains 6 and 11, 
which the vaccine also targets (Calder, 2009, pg. 20).  Currently, the vaccine is expected to 
provide protection against HPV “for at least 20 years,” but the precise extent of its effectiveness 
is unknown (Contraceptive Technology Update, 2008, pg. 127).  A booster may be administered 
later in life, yet this would be another cost to parents, while again placing their adolescent at risk 
for potential adverse effects of the Gardasil vaccination.  
Conclusion 
When considering Gardasil as mandatory school vaccination, we must remember that 
Gardasil is merely a preventative factor to contracting HPV, not a cure for cervical or other HPV 
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related cancers.  Abstinence is still the goal for teens and young adults and should be encouraged 
and taught in schools.  Still, there is a high chance that even if an individual waits until marriage 
to engage in sexual activity, that his or her partner could have or have been exposed HPV, unless 
it is their first time engaging in sexual intercourse, too.  While parents are disgruntled about the 
implications of this vaccine, the fact still remains that adolescents are engaging in sexual 
activities and therefore it is necessary to begin vaccination at such a young age.  Not only would 
mandatory vaccination protect adolescents later in life, but it may also protect those who are 
victims of sexual abuse.  It is unclear if the protection that Gardasil offers against HPV will be 
lifelong, but similar to other vaccines a booster dose could be provided later.    
This topic is extremely important to us as nurses since both medical providers and school 
educators need to be aware of media reporting in order to alleviate fears that the public may 
experience about the Gardasil vaccine.  Additionally it is our responsibility to inform adolescents 
as well as parents about the risk factors associated with contracting HPV; the importance of 
maintaining yearly Pap smears; and the usefulness of the Gardasil vaccine in preventing cervical 
cancer.  I personally have gained insight to the legislative process surrounding mandatory school 
vaccinations and the importance of educating all parties, not just the individual that may be 
receiving the vaccine.  It is evident that parents and practitioners must put aside their differences 
and recognize that Gardasil is one of the first vaccines that may actually prevent multiple forms 
of a cancer.  Therefore it is our duty as medical professionals and parents to do what is best for 
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